"We talk about the S-curve for technology and in the past we've said it can be 10 or 20 years before you reach the top. I think what's going to be really different about AI is that time frame is going ...

Acellera Therapeutics focuses on drug discovery by merging AI-driven innovation with computational scaleability, aiming to ...

Nobel Prize in Chemistry highlights AI advancements in protein science, transforming structure prediction and design with ...

A collaborative study between researchers from the Yong Loo Lin School of Medicine, National University of Singapore (NUS ...

The pharmaceutical industry is on the verge of a significant transformation due to the emergence of artificial intelligence ...

Scientists have pioneered a groundbreaking method to combat snake venom using newly designed proteins, offering hope for more ...

Quantum computing and artificial intelligence (AI) can be combined with classical computing methods to design and discover small-molecule candidates that target the cancer-driving KRAS protein, ...

Research co-led by University of Toronto researchers and Insilico Medicine has demonstrated the potential of quantum ...

With continued investment and growing buzz from the industry, the AI hype is expected to extend through 2025 and beyond.

This piece is part of a series that dives deeper into the most prevalent themes of this year’s iteration of our flagship research piece, Charting Disruption. Click to read.

Via AI methodologies, trial sponsors can simulate outcomes for different clinical development pathway scenarios to evaluate ...

While the presidential transition commanded headlines this week, equally significant shifts were occurring in AI technology. Just hours before Donald Trump’s inauguration, DeepSeek released its latest ...